Disease Info Card

Schistosomiasis Japonica

Information about Schistosomiasis Japonica: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Schistosomiasis Japonica

Most recent studies have shown that Schistosomiasis Japonica shares some biological mechanisms with carcinoma, endemic-diseases, fibrosis, granuloma, helminthiasis, hepatic-fibrosis, hepatitis, infective-disorder, inflammation, intestinal-schistosomiasis, liver-cirrhosis, liver-diseases, liver-diseases-parasitic, malaria, malignant-neoplasms, parasitic-diseases, parasitic-infection, schistosomiasis, schistosomiasis-mansoni, trematode-infections.

Among the many pathways, these few ones have gauged particular interests from scientists studying Schistosomiasis Japonica, and have been seen in publications frequently: Cell Proliferation, Cytokine Production, Excretion, Granuloma Formation, Hatching, Hypersensitivity, Immune Response, Inflammatory Response, Localization, Lymphocyte Proliferation, Oviposition, Pathogenesis, Proteolysis, Reverse Transcription, Rna Interference, Secretion, Sensitization, Swimming, Translation, Transport

Quite a number of genes have been found to play important roles in Schistosomiasis Japonica, such as C3, CARD16, CD4, GSTK1, IFNG, IL10, IL13, IL2, IL4, IL5, ITSN2, SFSWAP, SLC25A1, SLCO6A1, TNF, TPI1, YWHAQ. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.